Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who received surgery to remove breast cancer at Peking University People's Hospital and have hospital records from that treatment
- People whose post-surgery tissue testing confirmed invasive breast cancer meeting one of these two profiles: a tumour 1cm or smaller that is HER2-positive with at least one high-risk feature (either high-grade cancer cells or hormone receptor-negative status); or a tumour between 1cm and 2cm that is HER2-positive without high-risk features (lower-grade cancer cells and hormone receptor-positive status), with no spread to lymph nodes in either case
- People who have signed an agreement to take part in the PKUPH Breast Disease Cohort study at Peking University People's Hospital
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose clinical records are incomplete, such as missing imaging or tissue testing results
- People who received treatment before surgery to shrink the tumour (sometimes called neoadjuvant therapy)
- People whose breast cancer has spread to other parts of the body, or who have cancer in both breasts
- People who did not undergo full surgical removal of the cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+13671287670
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
invasive disease free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.